Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Chintu Patel Insider Profile

4 Followers

Chintu Patel, Co-CEO, Director at Amneal Pharmaceuticals, holds 32.52M shares in Amneal Pharmaceuticals (Ticker: AMRX).

Chintu Patel's Trading History

AMRXAmneal Pharmaceuticals		Aug 12, 2026Co-CEO, DirectorUninformative Buy―$699.58M
AMRX
Insider Shares: 32.52M (10.18%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 12, 2026Uninformative Buy$0.006,381,734$0.00―
Mar 05, 2026Uninformative Buy$6.98M524,488$13.30―
Mar 05, 2025Uninformative Buy$3.08M351,467$8.77―
Nov 08, 2023Uninformative Buy$0.0024,753,252$0.00―
Dec 17, 2021Informative Buy$625.50K150,000$4.17-47.70%
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Chintu Patel insider profile FAQ

What is the percentage of profitable transactions made by Chintu Patel?
The percentage of profitable transactions made by Chintu Patel is 67%.
What is the average return per transaction made by Chintu Patel?
The average return per transaction made by Chintu Patel is 42.30%.
What stocks does Chintu Patel hold?
Chintu Patel holds: AMRX stocks.
What was Chintu Patel's most profitable transaction?
Chintu Patel’s most profitable transaction was an Informative Buy of AMRX stock on March 11, 2020. The return on the trade was 88.90%.
What is Chintu Patel's role in Amneal Pharmaceuticals?
Chintu Patel's role in Amneal Pharmaceuticals is Co-CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.